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The object of this study was to evaluate the safety and meat quality criteria in broilers
following intramuscular injection of boldenone. Twenty-four broiler chicks, divided into two
groups, were used in the present study. Boldenone was injected intramuscularly at a single-
dose level of 5 mg/kg body weight into 12 broiler chicks at 2 weeks old; the other 12 chicks
were injected with sesame oil and kept as controls. Blood samples were collected from the
wing and metatarsal veins after 1, 2, and 3 weeks through the experimental course for
hematological and clinic-chemical safety parameters. On the last day, chicks were hu-
manely sacrificed and livers and kidneys were removed for histopathological examination.
Breast muscles were also removed to assess meat-quality parameters. Boldenone signifi-
cantly (p < 0.05) increased total erythrocytic count and hemoglobin and hematocrit values,
while mean corpuscular hemoglobin and mean corpuscular hemoglobin concentration
indices decreased. Leukogram showed leukopenia, lymphopenia, and granulocytosis (p <
0.05) as compared to control. Hepatorenal biomarkers, including alkaline phosphatase,
aspartate aminotransferase, alanine aminotransferase, urea, and creatinine were signifi-
cantly (p < 0.05) higher than the corresponding control values. Additionally, boldenone
significantly (p < 0.05) increased metabolic markers, including total protein, globulins,
cholesterol, triacylglycerols, and glucose, with parallel decreases in albumin and albumin/
globulin ratio. Degenerative changes were recorded in liver and kidney tissues from chicks
treated with boldenone. Muscle samples exhibited raised pH values and higher microbial
counts as compared to the corresponding control. These data may discourage the use of
boldenone as a growth promoter in broilers due to safety and meat quality reasons.
Copyright © 2016, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/3.0/).macology, Faculty of Vete
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Anabolic androgenic steroids are synthetic derivatives
structurally related to androgens (the male sex hormones).
These agents promote development of male sexual charac-
teristics (androgenic effects) and, thus, are used in treating
delayed puberty, impotence, and related conditions. They
also promote growth of skeletal muscle (anabolic effects) and
can be used in repairing wasting of the body caused by some
emaciating diseases [1]. However, these anabolic steroids can
be abused in human and animal sports for better perfor-
mance [2]. Also, they can be used for increasing body weight
in livestock as growth-promoting agents either legally or
illegally.
Growth-promoting implants have been used in the pro-
duction of cattle and sheep for >40 years. Such implants may
improve growth rates (approx. 10e30%), feed efficiency
(approx. 5e15%), and carcass leanness (approx. 5e8%). His-
torically, the earliest use of hormones as growth enhancers
in farm animal production included iodinated proteins in
dairy cows for increased milk production and estrogen im-
plants (diethylstilbestrol and dienestrol) in broilers for
enhanced fat deposition [3]. The first hormone used in beef
cattle and sheep for growth, efficiency, and lean meat pro-
motion was diethylstilbestrol in 1954 [4]. However, because of
potential carcinogenicity from the use of diethylstilbestrol in
humans, this compound was banned for use in 1979 by the
Food and Drug Administration (FDA). Parallel to this trend,
most hormonal growth promoters have been banned, and the
restricted use of only a few agents have been permitted.
Many countries permit the use of a short list of growth-
promoting steroid hormones to bulk up animals and in-
crease the yield of meat. The USA and Canada, in addition to
all developing countries, follow this practice; however, the EU
has banned the use of hormones in food-producing animals
due to health concerns [5].
Boldenone is an anabolic steroid that differs from testos-
terone by its high anabolic and low androgenic activities.
Therefore, it has been produced as a veterinary product as
boldenone undecylenate under various trade names for
improving meat mass in cattle and veal calves. Boldenone is
restricted to veterinary purposes only in some countries;
nonetheless, sports competitors and bodybuilders have been
known to administer this anabolic steroid. It was approved
by the U.S. FDA for use in horses; however, in most countries
worldwide, it is forbidden for meat production and human
use [6]. The control of boldenone for illegal uses was based on
the identification of either 17b-boldenone or 17a-boldenone
(the main metabolite in cattle) in edible tissues, hair, feces, or
urine [7]. Boldenone has been increasingly detected in a
number of biological samples in different EU member states.
The question arose concerning whether this increased
number of boldenone findings was due to the illegal treat-
ment of animals or whether, in some circumstances, bolde-
none could be of endogenous origin. For instance, it was
demonstrated that boldenone could be formed from phytos-
terols present in vegetable fat [8,9]. Previous studies were
conducted to study the effects and metabolism of boldenone
in various species, including horses [10], cattle [11], vealcalves [12], weaned lambs [13], rabbits [14,15], and human
volunteers [16].
No data are available concerning the altering effects of
boldenone administration to broilers as a popular farm animal
species. Therefore, this study was designed to investigate the
possible effects of boldenone on broiler chicks from safety and
meat quality aspects as a trial to evaluate its possible use as a
growth promoter in the broiler industry.2. Methods
2.1. Boldenone
Chemically, 17b-boldenone, also called 1-
dehydrotestosterone, androsta-1,4-diene-17b-ol-3-1, is a ste-
roid with androgenic activity that differs from 17b-testos-
terone by only one double bond at the 1 position. Esters of 17b-
boldenone (e.g., undecylenate ester) are pharmaceutically
produced as anabolic preparations for veterinary use. In the
present study, boldenone was obtained as the patent prepa-
ration Equigan (Laboratorios Tornel S.A., Mexico) that is an
intramuscular therapy for muscle building in equines. This
preparation is formulated as 10 mL glass vials containing
50 mg boldenone undecylenate/mL sesame oil. The drug was
administered intramuscularly in the thigh as single doses of
5 mg/kg body weight of broiler chick.
2.2. Experimental animals
Twenty-four Ross broiler chicks, aged 2 weeks and weighing
approximately 600 g, were used for the present study. Animals
were purchased from a local farm at 1 week old and kept in
our controlled environment for a further week for acclimati-
zation before use. All animals were maintained on standard
growing rations and water ad libitum. Animal care and
experimentationwere according to guidelines of the European
Commission Directive 86/609/EEC for animal experiments and
were approved by our local institutional committee.
2.3. Experimental design
A parallel design is followed in this study, where animals
were randomly divided into two groups (n ¼ 12 for each) and
labeled appropriately. The first group received 0.1 mL of
sesame oil (solvent of boldenone) intramuscularly in the
thigh muscle and kept as the control group. The second
group received a single dose of boldenone undecylenate
(5 mg/kg) as 0.1 mL of sesame oil-diluted Equigan injectable
solution in the same manner and kept as the treated group.
After different treatments, all animals were observed daily
for extraordinary symptoms throughout the period of study.
Blood samples were collected from the wing and metatarsal
veins using syringes with 22-gauge needles 1 week, 2 weeks,
and 3 weeks post-injection. The samples were received into
centrifuge tubes containing lithium heparin. Each sample
was divided into two parts, with the first kept as whole blood
for hematological analysis and the second centrifuged for
5 min at 12,000g to separate plasma that was used for the
clinicochemical study. At the end of experiment, all animals
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removed for histopathological examination. Also, pectoral
muscles on the keel bone were picked for meat-quality
examination.2.4. Hematological assays
To assess the blood-safety profile of boldenone, the following
hematological parameters were automatically evaluated by
auto-hematology analyzer (Mindray, Model BC-2800Vet,
Shenzhen, China). Erythrocytic parameters included red
blood cell (RBC) count, hematocrit value (Hct), mean corpus-
cular volume (MCV), hemoglobin concentration (Hgb), mean
corpuscular hemoglobin (MCH), and mean corpuscular he-
moglobin concentration (MCHC). Leukocytic parameters
included white blood cell (WBC) count, differential leukocyte
count (neutrophils, lymphocytes, monocytes, eosinophils,
and basophils), platelet (PLT) concentration, and mean
platelet volume (MPV). The analyzer adopted the Coulter
Principle to count RBC, WBC, and PLT cells and to draw their
corresponding histograms. The Hgb concentration was ob-
tained by the colorimetric method and the MCV was calcu-
lated electronically. The rest of the indices were
mathematically derived.2.5. Clinicochemical assays
Estimating plasma clinicochemical parameters and evalu-
ating hepatotoxicity, nephrotoxicity and/or metabotoxicity
was carried out spectrophotometrically (Model 6500, Jenway,
Germany) using diagnostic kits purchased from Analyticon
Biotechnologies AG (Lichtenfels, Germany). The parameters
were alkaline phosphatase [17], aspartate aminotransferase
[18], alanine aminotransferase [18], total protein [19], creatine
kinase [20], albumin [21], urea [22], creatinine [23], glucose [24],
and total cholesterol [25]. Plasma triacylglycerol level was
estimated using a diagnostic kit purchased from Biolabo SA
(Maizy, France) according to Fossati and Prencipe [26]. Glob-
ulin level was calculated by subtracting the value of albumin
from the value of total protein according to Doumas and Biggs
[27].2.6. Histopathological assay
The liver and the two kidneyswere taken from sacrificed birds
in both groups, preserved in formalin solution (10%), and
subjected for histopathological examination according to
Bancroft and Gamble [28].2.7. Determination of pH values of chicken breasts
(pectoralis) samples during cold-chilled storage
Chicken breasts (pectoralis) pH values for the boldenone and
control groups were determined after 2 h, 24 h, 48 h and 72 h
post mortem during cold storage at 4C. The measurement
was based on using a fiber-optic pH Meter (Jenway 3505 pH
Meter, Barloworld Scientific Ltd., Dunmow, UK) after cali-
brating using standard buffers at pH 4.0 and pH 7.0 (Merck
Millipore, Waltham, MA, USA). The glass electrodes weremechanically inserted into pre-opened pectoralis with a
sterile scalpel [29].
2.8. Microbiological Analysis
Two groups of chicken breasts (pectoralis) from boldenone-
treated and control groups were subjected for microbiolog-
ical analysis after 24-h storage at 4C. Preparation of samples,
decimal dilutions, culturing, and enumeration techniques for
bacteria were performed according to the methods described
by the American Public Health Association [30,31]. Briefly, 25 g
of the sample was removed with sterile scalpels and trans-
ferred to a sterile Stomacher bag (Stomacher 400, Seaward
Medicals, UK.) under aseptic conditions. The sample was then
diluted to a 10:1 dilution with 225 mL peptone water (M0216,
Park Scientific, Ltd., Northampton, UK) and stomached for
2 min using a Seward's Stomacher 400 Circulator (Stomacher
400, Seaward Medicals). Serial dilutions were then performed
using sterile 0.1% peptone water (Park Scientific, Ltd.). Deter-
mination of the aerobic plate count (APC) was performed
using plate-count agar (Difco Laboratories, Detroit, MI, USA),
inoculated with serial dilutions on triplicate agar plates, and
incubated at 37C for 48 h. Countable plates were those con-
taining from 25 to 250 colonies.
Determination of coliform count was performed using Vi-
olet Red Bile Lactose agar (VRBA, Park Scientific, Ltd.). VRBA
triplicate agar plateswere inoculated using an overlaymethod
and incubated at 37C for 24 h. Purple-red colonies, 0.5 mm in
diameter or larger, surrounded by a zone of precipitated bile
acids were counted.
Enumeration of total Staphylococci count was performed
using Baird-Parker agar (Park Scientific, Ltd.). The inoculums
were surface plated using a sterile bent-glass streaking rod on
triplicate agar plates. Plates were inverted and incubated at
37C for 48 h.
2.9. Statistical analysis
Results are expressed as mean ± standard error of the mean
for 12 observations (n). A factorial linear statistical model was
fitted to the data, and differences between the control and
treated group at different time points were tested for signifi-
cance using a one-way analysis of variance, followed by least-
significant difference post-hoc test. A p  0.05 was considered
significant. All statistical analytical procedures were done
using SPSS software version 20 (IBM Corp., Armonk, NY, USA).3. Results
The animals post-boldenone administration appeared lively
with good appetites and did not show any abnormal signs. No
mortalities were recorded throughout the experiment, and no
significant increases in body weight gain were recorded.
3.1. Hematological study
The administration of boldenone significantly affected both
the erythrocyte and leukocyte parameters as compared to the
control group (p > 0.05). A single dose of boldenone (second
Table 1 e Effects of single intramuscular injection of boldenone (5 mg/kg) on erythrocytic parameters of broilers over a 3-
week experimental course (mean ± SEM; n ¼ 12).
Group / Parameter RBC (1012/L) Hct (%) Hgb (g/dL) MCV (fL) MCH (pg) MCHC (g/dL)
1st w Control 2.20 ± 0.06 28.43 ± 0.77 13.00 ± 0.06 129.23 ± 0.15 59.16 ± 1.29 45.78 ± 1.03
Boldenone 2.33 ± 0.03 30.15 ± 0.44 13.32 ± 0.09 129.23 ± 0.12 57.08 ± 0.42 44.17 ± 0.33
2nd w Control 2.40 ± 0.06 30.49 ± 0.76 13.33 ± 0.12 127.03 ± 0.12 55.60 ± 0.86 43.76 ± 0.71
Boldenone 2.77 ± 0.03* 35.02 ± 0.43* 13.80 ± 0.06* 126.57 ± 0.12 49.89 ± 0.44* 39.42 ± 0.36*
3rd w Control 2.70 ± 0.06 33.83 ± 0.75 13.57 ± 0.03 125.30 ± 0.17 50.29 ± 1.09 40.14 ± 0.89
Boldenone 3.40 ± 0.15* 42.49 ± 1.91* 14.42 ± 0.17* 124.97 ± 0.18 42.53 ± 1.49* 34.04 ± 1.20*
* Significantly different from corresponding control (p < 0.05).
Hct ¼ hematocrit count; Hgb ¼ hemoglobin; MCH ¼ mean corpuscular hemoglobin; MCHC ¼ mean corpuscular hemoglobin concentration;
MCV ¼ mean corpuscular volume; RBC ¼ red blood cell.
Table 2 e Effects of single intramuscular injection of boldenone (5 mg/kg) on leukocytic parameters of broilers over a 3-
week experimental course (mean ± SEM; n ¼ 12).
Group / Parameter WBC (109/L) Lymph. (109/L) Mid. (109/L) Gran. (109/L) PLT (109/L) PCT (%) MPV (fL)
1st w Control 21.36 ± 0.31 8.92 ± 0.34 1.00 ± 0.12 11.43 ± 0.14 0.058 ± 0.01 0.033 ± 0.003 5.40 ± 0.06
Boldenone 20.53 ± 0.21 8.33 ± 0.12 0.94 ± 0.08 11.26 ± 0.15 0.056 ± .004 0.037 ± .003 5.73 ± 0.12
2nd w Control 21.88 ± 0.10 10.13 ± 0.30 1.183 ± 0.04 10.57 ± 0.241 0.073 ± 0.003 0.043 ± 0.003 5.83 ± 0.09
Boldenone 20.30 ± 0.12* 7.80 ± 0.17* 0.900 ± 0.06* 11.60 ± 0.10* 0.063 ± 0.003 0.033 ± 0.003 5.73 ± 0.08
3rd w Control 22.10 ± 0.12 13.50 ± 0.44 1.257 ± 0.03 9.85 ± 0.16 0.090 ± 0.006 0.050 ± 0.006 5.63 ± 0.09
Boldenone 20.47 ± 0.18* 8.83 ± 0.07* 0.960 ± 0.04* 10.57 ± 0.20* 0.080 ± 0.006 0.047 ± 0.003 5.70 ± 0.12
* Significantly different from corresponding control (p < 0.05).
Gran ¼ granulocyte; Lymph ¼ lymphocyte; Mid ¼mid-sized cells; MPV ¼mean platelet volume ; PCT ¼ plateletcrit; PLT ¼ platelet; WBC ¼white
blood cell.
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values in the 2nd and 3rd weeks. Meanwhile, MCH and MCHC
index values decreased. Boldenone significantly decreased
total leukocytic count, with changes in differential count,
where lymphocytes exhibited significant decreases and
granulocytes exhibited significant increases as compared to
control (Tables 1 and 2).3.2. Clinicochemical study
All hepatorenal function markers, including ALP, ALT, AST,
urea, and creatinine, showed significant increases as
compared to control according to the studied dose level of
boldenone. Additionally, cardiac function marker CK
showed significant increases after boldenone administration
(Table 3).Table 3 e Effects of single intramuscular injection of boldenone
over a 3-week experimental course (mean ± SEM; n ¼ 12).
Group / Parameter ALP (IU/L) AST (IU/L) ALT (I
1st w Control 464.0 ± 7.81 149.67 ± 4.33 24.90 ±
Boldenone 501.67 ± 6.01* 174.33 ± 2.96* 41.25 ±
2nd w Control 390.00 ± 5.77 162.03 ± 4.36 44.33 ±
Boldenone 468.33 ± 4.41* 198.33 ± 6.01* 68.33 ±
3rd w Control 325.00 ± 7.64 174.67 ± 3.48 60.33 ±
Boldenone 416.67 ± 8.82* 241.00 ± 6.66* 91.00 ±
* Significantly different from corresponding control (p < 0.05).
ALP ¼ alkaline phosphatase; ALT ¼ alanine aminotransferase; AST ¼ aspBoldenone also adversely affected metabolic parameters,
including significant increases in Tp and Glb concentrations,
without significant changes in Alb level as compared to con-
trol. Significant increases in Chol, Tag, and Glu were also
recorded (Table 4).3.3. Histopathological study
No histopathological alterations and normal histological
structure of the central and portal veins and surrounding
hepatocyteswas recorded. However, the liver of chicks treated
with boldenone showed mild dilatation in the portal veins
associated with diffuse inflammatory cell infiltration in be-
tween the hepatocytes (Figure 1).
Similarly, no histopathological alteration in the kidney of
the control chicks and normal histological structure of the
glomeruli and tubules at the cortex were recorded. Boldenone(5 mg/kg) on liver and renal function parameters of broilers
U/L) CK (IU/L) Urea (mg/dL) Creatinine (mg/dL)
2.98 80.00 ± 5.77 15.00 ± 1.15 0.32 ± 0.04
2.14* 105.00 ± 2.89* 28.33 ± 2.40* 0.63 ± 0.06*
5.21 96.00 ± 3.79 17.67 ± 1.45 0.39 ± 0.02
4.41* 114.00 ± 3.06* 35.00 ± 2.89* 0.74 ± 0.04*
3.18 108.33 ± 4.06 22.33 ± 1.76 0.39 ± 0.01
5.51* 130.33 ± 2.60* 53.33 ± 4.41* 0.72 ± 0.04*
artate aminotransferase; CK ¼ creatine kinase.
Table 4 e Effects of single intramuscular injection of boldenone (5 mg/kg) on somemetabolic parameters of broilers over a
3-week experimental course (mean ± SEM; n ¼ 12).
Group / Parameter Tp (g/dL) Alb (g/dL) Glb (g/dL) Chol (mg/dL) Tag (mg/dL) Glu (mg/dL)
1st w Control 4.23 ± 0.18 1.72 ± 0.09 2.51 ± 0.09 110.33 ± 5.78 53.18 ± 3.25 197.00 ± 3.79
Boldenone 4.80 ± 0.10* 1.80 ± 0.03 2.99 ± 0.09* 128.33 ± 3.28* 65.00 ± 3.21* 199.00 ± 4.36
2nd w Control 4.90 ± 0.12 2.03 ± 0.06 2.87 ± 0.06 109.67 ± 2.91 53.33 ± 3.76 176.00 ± 6.03
Boldenone 5.50 ± 0.12* 2.02 ± 0.05 3.48 ± 0.07* 141.00 ± 3.21* 76.00 ± 2.08* 193.00 ± 2.31*
3rd w Control 5.40 ± 0.12 2.27 ± 0.02 3.13 ± 0.10 115.67 ± 2.96 58.33 ± 4.26 175.00 ± 2.08
Boldenone 6.10 ± 0.12* 2.16 ± 0.04 3.94 ± 0.08* 160.33 ± 9.21* 87.00 ± 5.29* 196.67 ± 3.38*
* Significantly different from corresponding control (p < 0.05).
Alb ¼ albumin; Chol ¼ cholesterol; Glb ¼ globulin; Glu ¼ glutamate; Tag ¼ triglyceride; Tp ¼ total protein.
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renal tubules and around the congested blood vessels asso-
ciated with appearance of homogenous eosinophilic casts in
the lumen of dilated tubules (Figure 2).3.4. Meat quality study
3.4.1. pH value
The pH of meat influences its color, water-holding capacity,
flavor, tenderness, and shelf-life. Itsmeasurement at different
times post mortem provides information about forthcoming
quality characteristics [29].
The pH values of chicken breasts (pectoralis) at 2 h, 24 h,
48 h, and 72 h post mortem during cold chilled storage (4C) of
the control group were stable (6.03 ± 0.025, 6.11 ± 0.022,
6.09 ± 0.023, and 6.1 ± 0.027, respectively; n ¼ 3, p < 0.05).
However, pH values of breasts from the boldenone-treated
group were significantly raised from 6.043 ± 0.04 to 6.3 ± 0.04
after 24-h chilled storage (n ¼ 3, p < 0.05; Figure 3).
3.4.2. Total bacterial count
APC, Staphylococci, and coliform counts were compared be-
tween chicken breasts (pectoralis) from the boldenone-treated
group and the control group with APC (32  105 ± 12  104 vs.Figure 1 e Histological section of liver from a boldenone-
treated broiler chick showing mild dilatation in the central
veins associated with diffuse inflammatory cell infiltration
in between the hepatocytes (H&E 40£).
H&E ¼ Hematoxylin and eosin.17  105 ± 53  104 cfu/g; n ¼ 3, p < 0.05), Staphylococci
(66 103 ± 76 102 vs. 21 103 ± 38 102 cfu/g; n ¼ 3, p < 0.05),
and coliform count (82  104 ± 36  103 vs. 71  103 ±
26  103 cfu/g; n ¼ 3, p < 0.05) shown in Figure 4.4. Discussion
Boldenone is an anabolic steroid characterized by high
anabolic and low androgenic activities. 17b-Boldenone, also
called 1-dehydrotestosterone, androsta-1,4-diene-17b-ol-3-1,
is a steroid with androgenic activity that differs from 17b-
testosterone by only one double bond at the 1 position.
Important steroids closely related to 17b-boldenone and 17b-
testosterone are the 17b-boldenone epimer, i.e., 17a-bolde-
none, androsta-1,4-diene-3,17-dione, and androst-4-ene-3,17-
dione. The two latter diketo substances are precursors of 17b-
boldenone and 17b-testosterone, respectively, in humans and
different animal species. 17b-Boldenone, esters of 17b-bolde-
none (e.g., undecylenate ester), and androsta-1,4-diene-3,17-
dione are available for open sale as anabolic preparations [8,9].
Boldenone has been used in many countries for improving
meat mass in animals and in body building for humans.
Anabolic steroids, including boldenone, are thought to exertFigure 2 e Histological section of a kidney from a
boldenone-treated broiler chick showing congestion of
blood vessels with focal inflammatory cell infiltration in
between glomeruli and tubules (H&E 40£).
H&E ¼ Hematoxylin and eosin.
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modulating androgen receptor expression as a consequence
of (1) intracellular metabolism and (2) directly affecting the
topology of the androgen receptor and, thus, subsequent
interaction with co-activators and transcriptional activity.
Other mechanisms include an anticatabolic effect by inter-
fering with glucocorticoid receptor expression and by non-
genomic and genomic pathways in the central nervous sys-
tem resulting in behavioral changes [32].
Unsupervised use of boldenone and similar drugs is
sometimes associated with adverse effects or any other
possible drug-related problems. This study was designed to
evaluate the possible use of boldenone as a growth promoter
in broiler chicks regarding its safety and meat-quality
changes.
The supranormal levels of RBC parameters (number, Hct
and Hgb concentration) calculated by automated cell counter
indicated that boldenone administration enhanced erythro-
poiesis processes. This result may be supported by Donaldson
et al. [33], who found that anabolic steroids stimulated
erythropoiesis by increasing erythropoietin-stimulating fac-
tor. The data are also consistent with Alen [34], who reported
increases in these parameters in athletes on anabolic steroids;
however, his description regarding MCH and MVHC was0
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Figure 4 e Effect of boldenone on growth of indicator
bacteria in chicken breasts (pectoralis) during cold-chilled
storage (24 h at 4C). APC ¼ aerobic plate count.different from our findings. Other recent investigations also
reported similar results in rabbits [14], calves [12], and lambs
[13]. However, horses were reported to exhibit no significant
changes in Hgb and Hct values [35]. RBC size is expressed by
the MCV in femtoliters (fL) and usually reflects the degree of
regeneration from anemia. Macrocytosis (an increase in the
MCV) usually correlates with regenerative anemia, i.e., the
bone marrow is reactive to repair the occurred decrease in
blood parameters. Microcytic RBCs are the hallmark of iron-
deficiency anemia [36]. Here, MCV was insignificantly
changed, indicating no anemia. MCH and MCHC are two
indices correlating Hgb concentration to either RBC count or
Hct value, respectively. Although the Hgb value was signifi-
cantly increased by boldenone, these indices were decreased
due to the parallel increase in both RBC count and Hct value.
Leuckocytic parameters showed significant changes as
compared to those of the control. Total leuckocytic count
decreased as a result of the decreased number of lymphocytes
(lymphopenia), which constituted themajor percentage of the
differential count. In contrast, the number of granulocytes
exhibited significant increases (granulocytosis). Increased
numbers of granulocytes are an indicator of inflammation
caused by boldenone in the liver and kidney, as indicated by
biomarkers, as well as histopathology. Decreased numbers of
lymphocytes despite the increased globulin concentration in
this study may have indicated that the increment of globulin
concentration could be attributed to the increased levels of a-
and b-fractions of globulins rather than the g-fractions. The
former are biomarkers of inflammation, while the latter are
biomarkers of immunity. Positive acute-phase proteins
represent plasma proteins that increase significantly during
acute systemic response to inflammation. These include
haptoglobin, fibrinogen, C-reactive protein, serum amyloid-A,
and a1-acid glycoprotein [37]. Lymphopenia may also be
attributed to its redistribution among different body com-
partments after anabolic steroid administration [38]. The
recorded lymphopenia was consistent with the findings of
Saleh andWaded [39], who reported decreased immunological
parameters in rabbits after boldenone administration in
particularly large doses.
Estimation of some biomarkers, such as the activities of
enzymes in blood, tissues, and body fluids, plays a major role
in assessment of drug safety. Here, the biomarkers in the
tested group showed significant differences from those of the
control group. ALP, ALT, and AST activity values at the tested
dose of boldenone were significantly increased as compared
to those of the controls. ALT is a cytoplasmic enzyme, and its
increased level in plasma is an indication of mild injuries
caused by the drug to the liver, while AST is a mitochondrial
enzyme whose increased activity in plasma reflects severe
hepatic-tissue injury [40]. It should be noted that althoughALP
is formedmostly in the liver, it is nonspecific to hepatic injury,
as it is also formed by other tissues, such as bone, kidney,
skeletal muscle, and placenta. Degenerative changes in the
liver tissue shown in Figure 1 may support hepatic injury
caused by boldenone administration. Oral administration
may be more stressful on the liver relative to injection due to
the first-pass effect. It is also worth noting that ALP concen-
tration in juvenile birds is significantly higher than that of
adult birds, as it is induced by increased cellular activity and
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 4 ( 2 0 1 6 ) 2 8 4e2 9 2290synthesis rather than cell damage. In contrast to mammals,
ALP in birds is also found at higher concentrations in duo-
denum and kidney [41].
The observed significant increase in urea and creatinine
values after boldenone injection suggested that the drugmight
cause renal damage. This biochemical result confirms the
histopathological alterations recorded in kidney samples taken
from the tested group (Figure 2). As urea is metabolized only in
the liver, its elevation also indicates hepatic dysfunction, as
discussed earlier. In normal birds, the pool of creatine from
which creatinine is formed depends mainly upon muscle
mass, and is mostly excreted before being converted to creat-
inine. Therefore, the level interval of creatinine in the blood of
birds is 0.1e0.4 mg/dL, which is much lower than that of
mammals [42]. Urea is also found in much lower concentra-
tions in normal birds than that of normal mammalian species.
Elevated levels of CK in this study indicated an adverse
effect of boldenone on cardiac and/or skeletal muscle. Multi-
ple investigations reported that boldenone abuse was associ-
ated with occurrences of serious cardiovascular events in
young athletes, including development of cardiomyopathy,
atrial fibrillation, infarction, disturbances of hemostatic sys-
tem, and ventricular thrombosis [43]. In animals, the organ
dysfunction data recorded in broilers in this study may be
parallel with those recorded in some other species, including
rats [44], rabbits [15], and lambs [11].
Although hypoproteinemia is an established finding in
liver damage [45], given that the liver creates most plasma-
protein fractions, here, the total plasma protein and globulin
concentrations were significantly increased after boldenone
administration. These findings could be attributed to the
nitrogen-retention capacity of the drug. Additionally, as
mentioned earlier, the increment of globulins may be attrib-
uted to the increased a- and b-fractions rather than the g-
fractions, including positive acute-phase proteins. Albumin,
in contrast, is considered a negative acute-phase protein that
is decreased in inflammation, especially hepatic. Although the
calculated albumin/globulin ratio was decreased, albumin
concentrations showed insignificant changes in the present
study.
Parallel elevation of Chol, Tag, and Glu is also a result of
liver injury, as lipid and carbohydrate products are managed
by the liver to maintain their physiological limits. Blood
should be routinely cleared from supra-normal levels of Chol
and Tag by a healthy liver with the help of lipoproteins and
lipases. Chol is utilized in the synthesis of steroidal hormones
and Tag is stored in fat cells for energy when needed. Glu
should be converted to glycogen by the liver and muscles, as
well. A diseased liver, therefore, results in what is called
“Metabolic Syndrome”, as indicated by elevated Chol, Tag, and
Glu. Metabolic results in broilers recorded in the present study
were consistent with this general rule, and with data reported
by other investigators [46].
Here, pH values of breast meat from the boldenone-treated
group were significantly higher as compared to those of the
control. Myofibrillar refraction contributed to differences in
light scattering between pale, soft, exudative and dark, firm,
dry chicken meat, as it does in pork and beef [47]. This phe-
nomenon was evident when comparing the meat quality of
chicken breasts (pectoralis) at low pH (5.91 ± 0.12, n ¼ 10) withbreasts at high pH (6.36 ± 0.25, n ¼ 10, p < 0.001). Low-pH
breasts had the highest reflectance (p < 0.001; from 400 nm
to 700 nm). High-pH breasts had the greatest transmittance
into their depth and across individual muscle fibers (p < 0.001).
The differences in refractive index between ordinary and
extraordinary rays across individual muscle fibers were
greater in low-pH relative to high-pH breasts (p < 0.001). Light
at low wavelengths had greater reflectance and lower trans-
mittance relative to light at long wavelengths (p < 0.001) [47].
In Brown Swiss veal calves, boldenone administration slowed
the process of carcass acidification in the first 24 h post mortem;
however, the ultimate pH value resulted in the custom. Meat
cutting at 7 days post mortem showed that treatment improved
the meat shininess and color [48].
The quality and safety ofmeat is dictated by the nature and
number of spoilage and pathogenic species, which form the
total flora. The microbiology of meat is, therefore, normally
considered according to two criteria: total bacterial counts,
also known as aerobic colony count; and APC and total viable
count provide an indication of gross levels of contamination.
Specific counts of species are related to spoilage or pathogenic
bacteria of particular significance, for example, Salmonella
spp., Enterobacteriaceae, and generic Escherichia coli [49]. In the
present study, APC, Staphylococci, and coliform counts were
much higher in chicken breasts (pectoralis) from the
boldenone-treated group as compared to the control group. It
is worth noting that there is a significant relationship between
meat pH and shelf life, as high ultimate pH increases the
vulnerability of meat to growth of spoilage bacteria [49].
In conclusion, the results of the this study indicated that
boldenone may cause hepatotoxic and nephrotoxic effects, as
well as reductions in meat quality in broilers. Therefore, its
use as a growth enhancer is discouraged in this species.Conflicts of interest
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